Table 4.
18-month changes in log-adjusted inflammatory biomarker parameter estimates and 95% confidence intervals, per unit change in measures of body adiposity, for individual undergoing intentional weight loss, only.
Change in body mass and adiposity measures | Δ Log-Adjusted CRP (mg/L) | Δ Log-Adjusted IL-6 (pg/mL) | ||||||
---|---|---|---|---|---|---|---|---|
Estimate | 95% CI | p-value | AIC* | Estimate | 95% CI | p-value | AIC* | |
Δ Total body mass (kg) | 0.05 | (0.03,0.06) | <0.01 | 266.7 | 0.02 | (0.01,0.02) | <0.01 | 184.0 |
Δ BMI (kg/m2) | 0.15 | (0.11,0.19) | <0.01 | 265.3 | 0.05 | (0.03,0.08) | <0.01 | 182.2 |
Δ Total body fat mass (kg) | 0.06 | (0.04,0.08) | <0.01 | 271.2 | 0.02 | (0.01,0.04) | <0.01 | 181.3 |
Δ Percent body fat (%) | 0.08 | (0.05,0.11) | <0.01 | 276.8 | 0.03 | (0.01,0.05) | <0.01 | 182.9 |
Δ Total abdominal fat volume (per 1000 cm3) | 0.37 | (0.24,0.51) | <0.01 | 271.1 | 0.19 | (0.11,0.28) | <0.01 | 191.4 |
Δ Abdominal visceral fat volume (per 1000 cm3) | 0.79 | (0.50,1.08) | <0.01 | 269.7 | 0.35 | (0.15.0.55) | <0.01 | 193.3 |
Δ Abdominal subcutaneous fat volume (per 1000 cm3) | 0.57 | (0.33,0.80) | <0.01 | 276.5 | 0.33 | (0.18,0.48) | <0.01 | 189.2 |
Δ Abdominal intermuscular fat volume (per 1000 cm3) | 5.00 | (0.66,9.34) | 0.02 | 284.8 | 2.75 | (0.02,5.49) | 0.05 | 191.0 |
Δ Total thigh fat volume (per 1000 cm3) | 0.88 | (0.26,1.49) | <0.01 | 288.1 | 0.21 | (−0.20,0.61) | 0.31 | 195.4 |
Δ Thigh intermuscular fat volume (per 1000 cm3) | 6.31 | (−4.14,16.76) | 0.23 | 286.9 | 3.61 | (−2.99,10.20) | 0.28 | 189.7 |
Δ Thigh subcutaneous fat volume (per 1000 cm3) | 0.94 | (0.29,1.59) | <0.01 | 287.8 | 0.21 | (−0.21,0.64) | 0.32 | 195.3 |
Results presented for the D and D+E arms, only. Model estimates adjust for randomization group, race, gender, age and baseline outcome measure. CT-derived measures of adiposity are expressed per 1000 cm3.
Akike’s Information Criteria (AIC) estimates are calculated among participants with baseline and follow-up weight, BMI, DXA, and CT measures (n=98).